Aileron Therapeutics News

Aileron Therapeutics Analyst Ratings

BenzingaApr 18 08:37 ET

Ladenburg Thalmann Upgrades Aileron Therapeutics to Buy, Announces $9 Price Target

BenzingaDec 1, 2023 11:43 ET

Aileron Therapeutics Analyst Ratings

BenzingaDec 1, 2023 11:40 ET

Analysts Offer Insights on Healthcare Companies: Aileron Therapeutics (ALRN) and OrthoPediatrics (KIDS)

TipRanksNov 1, 2022 11:55 ET

Analysts' Opinions Are Mixed on These Healthcare Stocks: Henry Schein (HSIC), Aileron Therapeutics (ALRN) and EFFECTOR Therapeutics (EFTR)

TipRanksOct 26, 2022 19:35 ET

Analysts Conflicted on These Healthcare Names: Celsion (CLSN), Aileron Therapeutics (ALRN) and Monopar Therapeutics Inc (MNPR)

TipRanksAug 16, 2022 06:35 ET

HC Wainwright Adjusts Price Target on Aileron Therapeutics to $1 From $2, Reiterates Buy Rating

MT NewswiresJun 30, 2022 21:59 ET

Aileron Therapeutics Is Maintained at Buy by HC Wainwright & Co.

Dow JonesJun 30, 2022 06:30 ET

Aileron Therapeutics Price Target Cut to $1.00/Share From $2.00 by HC Wainwright & Co.

Dow JonesJun 30, 2022 06:30 ET

Analysts Offer Insights on Healthcare Companies: Aileron Therapeutics (ALRN), NRX Pharmaceuticals (NRXP) and Cybin (CYBN)

TipRanksJun 30, 2022 06:21 ET

Aileron Therapeutics analyst ratings

Benzinga Analyst RatingsJun 30, 2022 06:21 ET

HC Wainwright & Co. Maintains Buy on Aileron Therapeutics, Lowers Price Target to $1

Benzinga Real-time NewsJun 30, 2022 06:20 ET

Aileron Therapeutics Cut to Market Perform From Outperform by William Blair

Dow JonesJun 29, 2022 14:03 ET

Aileron Therapeutics analyst ratings

Benzinga Analyst RatingsJun 29, 2022 13:54 ET

Ladenburg Thalmann Initiates Coverage on Aileron Therapeutics With Buy Rating, $2 Price Target

MT NewswiresJun 13, 2022 09:19 ET